C1CO34 Stock Overview
Cencora, Inc. sources and distributes pharmaceutical products. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Cencora, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$717.12 |
| 52 Week High | US$717.12 |
| 52 Week Low | US$490.78 |
| Beta | 0.44 |
| 11 Month Change | 7.56% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | 106.43% |
| 5 Year Change | n/a |
| Change since IPO | 288.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| C1CO34 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | 0% | -2.3% | 0.9% |
| 1Y | n/a | -15.1% | -0.4% |
Return vs Industry: Insufficient data to determine how C1CO34 performed against the BR Healthcare industry.
Return vs Market: Insufficient data to determine how C1CO34 performed against the BR Market.
Price Volatility
| C1CO34 volatility | |
|---|---|
| C1CO34 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.9% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in BR Market | 8.1% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: C1CO34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine C1CO34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 46,000 | Bob Mauch | www.cencora.com |
Cencora, Inc. sources and distributes pharmaceutical products. The company’s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.
Cencora, Inc. Fundamentals Summary
| C1CO34 fundamental statistics | |
|---|---|
| Market cap | R$278.81b |
| Earnings (TTM) | R$8.76b |
| Revenue (TTM) | R$1.71t |
31.8x
P/E Ratio0.2x
P/S RatioIs C1CO34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| C1CO34 income statement (TTM) | |
|---|---|
| Revenue | US$293.96b |
| Cost of Revenue | US$283.99b |
| Gross Profit | US$9.96b |
| Other Expenses | US$8.45b |
| Earnings | US$1.51b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.70 |
| Gross Margin | 3.39% |
| Net Profit Margin | 0.51% |
| Debt/Equity Ratio | 557.8% |
How did C1CO34 perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield27%
Payout RatioDoes C1CO34 pay a reliable dividends?
See C1CO34 dividend history and benchmarks| Cencora dividend dates | |
|---|---|
| Ex Dividend Date | Nov 13 2024 |
| Dividend Pay Date | Dec 05 2024 |
| Days until Ex dividend | 11 days |
| Days until Dividend pay date | 11 days |
Does C1CO34 pay a reliable dividends?
See C1CO34 dividend history and benchmarks